从利他的脐带献血计划中获得脐带间充质干细胞

Aina Arbós , Francesca Nicolau , Marta Quetglas , Joana Maria Ramis , Marta Monjo , Josep Muncunill , Javier Calvo , Antoni Gayà
{"title":"从利他的脐带献血计划中获得脐带间充质干细胞","authors":"Aina Arbós ,&nbsp;Francesca Nicolau ,&nbsp;Marta Quetglas ,&nbsp;Joana Maria Ramis ,&nbsp;Marta Monjo ,&nbsp;Josep Muncunill ,&nbsp;Javier Calvo ,&nbsp;Antoni Gayà","doi":"10.1016/j.inmuno.2012.11.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Mesenchymal stem cells (MSC) offer a great potential for regenerative medicine due to their unique properties of self-renewal, high plasticity and modulation of immune response. Although the original source of MSC has been bone marrow, there is a clear need for a source of MSC as an “off-the-shelf” product for quick and effective treatment. One of the first candidates was the umbilical cord blood (UCB) but the poor recovery discourages its use.</p></div><div><h3>Material and methods</h3><p>In the present paper, we tested umbilical cord (UC) tissue as a source for obtaining MSC. All the samples were obtained from donations included in our UCB altruistic procurement program.</p></div><div><h3>Results</h3><p>Our results showed that is possible to obtain MSC from UC (hUC-MSC) with a 100% success rate by using a combination of mechanical fragmentation and enzymatic digestion. The MSC thus obtained show a phenotype very similar to that observed in the MSC of bone marrow origin: CD45<sup>−</sup>CD31<sup>−</sup>CD34<sup>−</sup>HLA-DR-CD<sup>−</sup>105<sup>+</sup>CD90<sup>+</sup>CD73<sup>+</sup>. In addition, we have demonstrated that hUC-MSC, like the MSC from bone marrow, are able to differentiate into osteoblasts and adipocytes, and also exert a suppressive effect on the proliferative capacity of peripheral lymphocytes stimulated with phytohaemagglutinin.</p></div><div><h3>Conclusions</h3><p>We conclude that it is possible to implement a structured program of MSC derivation by using the same logistics that are used to obtain UCB. This opens the way to developing a biobank of human MSC that could be useful for research and clinical use.</p></div>","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"32 1","pages":"Pages 3-11"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2012.11.002","citationCount":"3","resultStr":"{\"title\":\"Obtención de células madre mesenquimales a partir de cordones umbilicales procedentes de un programa altruista de donación de sangre de cordón\",\"authors\":\"Aina Arbós ,&nbsp;Francesca Nicolau ,&nbsp;Marta Quetglas ,&nbsp;Joana Maria Ramis ,&nbsp;Marta Monjo ,&nbsp;Josep Muncunill ,&nbsp;Javier Calvo ,&nbsp;Antoni Gayà\",\"doi\":\"10.1016/j.inmuno.2012.11.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Mesenchymal stem cells (MSC) offer a great potential for regenerative medicine due to their unique properties of self-renewal, high plasticity and modulation of immune response. Although the original source of MSC has been bone marrow, there is a clear need for a source of MSC as an “off-the-shelf” product for quick and effective treatment. One of the first candidates was the umbilical cord blood (UCB) but the poor recovery discourages its use.</p></div><div><h3>Material and methods</h3><p>In the present paper, we tested umbilical cord (UC) tissue as a source for obtaining MSC. All the samples were obtained from donations included in our UCB altruistic procurement program.</p></div><div><h3>Results</h3><p>Our results showed that is possible to obtain MSC from UC (hUC-MSC) with a 100% success rate by using a combination of mechanical fragmentation and enzymatic digestion. The MSC thus obtained show a phenotype very similar to that observed in the MSC of bone marrow origin: CD45<sup>−</sup>CD31<sup>−</sup>CD34<sup>−</sup>HLA-DR-CD<sup>−</sup>105<sup>+</sup>CD90<sup>+</sup>CD73<sup>+</sup>. In addition, we have demonstrated that hUC-MSC, like the MSC from bone marrow, are able to differentiate into osteoblasts and adipocytes, and also exert a suppressive effect on the proliferative capacity of peripheral lymphocytes stimulated with phytohaemagglutinin.</p></div><div><h3>Conclusions</h3><p>We conclude that it is possible to implement a structured program of MSC derivation by using the same logistics that are used to obtain UCB. This opens the way to developing a biobank of human MSC that could be useful for research and clinical use.</p></div>\",\"PeriodicalId\":88896,\"journal\":{\"name\":\"Inmunologia (Barcelona, Spain : 1987)\",\"volume\":\"32 1\",\"pages\":\"Pages 3-11\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.inmuno.2012.11.002\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Inmunologia (Barcelona, Spain : 1987)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0213962612001205\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inmunologia (Barcelona, Spain : 1987)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213962612001205","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

间充质干细胞(MSC)具有自我更新、高可塑性和调节免疫反应的独特特性,在再生医学领域具有巨大的潜力。虽然骨髓间充质干细胞的原始来源是骨髓,但显然需要一种“现成的”产品来快速有效地治疗骨髓间充质干细胞。最早的候选之一是脐带血(UCB),但恢复不佳阻碍了它的使用。材料和方法在本文中,我们测试了脐带(UC)组织作为获得MSC的来源。所有样本均来自UCB无私采购计划的捐赠。结果采用机械破碎和酶解相结合的方法,可获得UC细胞间充质干细胞(hUC-MSC),成功率为100%。由此获得的MSC显示出与骨髓来源的MSC非常相似的表型:CD45 - CD31 - CD34 - HLA-DR-CD - 105+CD90+CD73+。此外,我们已经证明hUC-MSC与来自骨髓的MSC一样,能够分化成成骨细胞和脂肪细胞,并且对植物血凝素刺激的外周淋巴细胞的增殖能力也有抑制作用。我们得出的结论是,通过使用与获得UCB相同的物流来实现MSC衍生的结构化程序是可能的。这为开发可用于研究和临床使用的人类MSC生物库开辟了道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Obtención de células madre mesenquimales a partir de cordones umbilicales procedentes de un programa altruista de donación de sangre de cordón

Introduction

Mesenchymal stem cells (MSC) offer a great potential for regenerative medicine due to their unique properties of self-renewal, high plasticity and modulation of immune response. Although the original source of MSC has been bone marrow, there is a clear need for a source of MSC as an “off-the-shelf” product for quick and effective treatment. One of the first candidates was the umbilical cord blood (UCB) but the poor recovery discourages its use.

Material and methods

In the present paper, we tested umbilical cord (UC) tissue as a source for obtaining MSC. All the samples were obtained from donations included in our UCB altruistic procurement program.

Results

Our results showed that is possible to obtain MSC from UC (hUC-MSC) with a 100% success rate by using a combination of mechanical fragmentation and enzymatic digestion. The MSC thus obtained show a phenotype very similar to that observed in the MSC of bone marrow origin: CD45CD31CD34HLA-DR-CD105+CD90+CD73+. In addition, we have demonstrated that hUC-MSC, like the MSC from bone marrow, are able to differentiate into osteoblasts and adipocytes, and also exert a suppressive effect on the proliferative capacity of peripheral lymphocytes stimulated with phytohaemagglutinin.

Conclusions

We conclude that it is possible to implement a structured program of MSC derivation by using the same logistics that are used to obtain UCB. This opens the way to developing a biobank of human MSC that could be useful for research and clinical use.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信